Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$99,453,618
+$53,798,967 QoQ
Shares Held
1,726,026
+129.3% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#109
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Sep 30, 2022CallValue
$1,116,113
CallShares
15,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $1,312,781,180 across 10 Drug Manufacturers - General names. BMY ranks #7 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,191,725 | $281,636,662 | |
| 2 | JNJ |
Johnson & Johnson
|
886,454 | $225,132,721 | |
| 3 | LLY |
ELI LILLY & Co
|
173,376 | $207,952,392 | |
| 4 | NVO |
Novo Nordisk A S
|
3,065,015 | $146,936,818 | |
| 5 | PFE |
Pfizer Inc
|
4,423,296 | $106,512,967 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
791,956 | $100,055,721 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
1,726,026 | $99,453,618 | |
| 8 | ABBV |
AbbVie Inc.
|
337,881 | $85,024,374 |
All Filings in BMY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,453,618 | 1,726,026 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $45,654,651 | 752,756 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $43,323,097 | 803,172 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,076,116 | 755,568 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,643,499 | 532,372 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,279,045 | 348,894 | Shares | Sole | 2025-07-02 | |
| 2024-12-31 | $32,903,780 | 581,750 | Shares | Sole | 2025-07-02 | |
| 2024-09-30 | $24,071,362 | 465,237 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,139,477 | 557,175 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $51,019,853 | 940,805 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $71,337,882 | 1,390,331 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $12,128,618 | 208,970 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,755,096 | 183,817 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $10,823,795 | 156,165 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $14,788,170 | 205,534 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,116,113 | 15,700 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $14,323,639 | 201,486 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $68,957,581 | 895,553 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $23,120,274 | 316,586 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $104,783,851 | 1,680,575 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $44,164,783 | 746,405 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $20,709,500 | 350,000 | Put | Defined | 2021-11-12 | |
| 2021-06-30 | $24,643,949 | 368,811 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $33,362,373 | 528,471 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $90,751,005 | 1,463,018 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $139,667,210 | 2,316,590 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $190,040,129 | 3,231,975 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $92,653,758 | 1,662,249 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||